FDA Inspection 803415 — Radnostix

Radnostix — FEI 3003350319

The FDA completed an inspection of Radnostix on October 19, 2012 in Idaho Falls, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 19, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Idaho Falls, ID (United States)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
177421 CFR 211.142(a)Quarantine - actual practice
191421 CFR 211.166(a)Lack of written stability program
431421 CFR 211.84(d)(2)Reports of Analysis (Components)